Home
Galileo Biotech

Galileo Biotech Market Share Analysis for June 2026

Candidate-se à posição de Cientista Pós-Doutorado em Biologia Celular na Galileo Biotech e contribua para transformar a vida de pacientes que sofrem de necessidades médicas não atendidas.

Industry: N/A

Domaingalileobio.com

Year Founded2015

Employees51 - 200

Annual Revenue$5M - $10M

Galileo Biotech

Galileo Biotech (including company regionals)

galileobio.com

See more website traffic and engagement information

Galileo Biotech Revenue up to June 2026 is 5M - 10M

revenue generated by Galileo Biotech top domains

Galileo Biotech top domains revenue over 3 years

Revenue for Galileo Biotech top domains

galileobio.com5M - 10M

See more with Sales Intelligence

Total visits to Galileo Biotech's top domains

Understand Galileo Biotech market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Galileo Biotech's top domains

Analyze Galileo Biotech engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Galileo Biotech's top domains

See how Galileo Biotech keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Galileo Biotech top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Galileo Biotech

These are the website technologies, by industry, used by Galileo Biotech top domains

Widget (5)

reCAPTCHA

Content Management System (3)

WordPress

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

More Technologies

3

See all

News & Signals from Galileo Biotech

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTillat Pharmaceuticals, Inc. partnered with Galileobio on Dec 1st '23.Tillat Pharmaceuticals and Galileo Biotech partner to co-develop halal therapeutic monoclonal antibodies targeting oncological disorders and other leading diseases.

NewsAntharis Therapeutics, Inc. acquired Galileobio on Aug 1st '23.SAN DIEGO, CA - August 23, 2023 - Antharis Therapeutics, a four-year-old biopharmaceutical company developing a leading portfolio of oncology-related immunotherapeutics, today announced the completion of its acquisition of Galileo Biotech.